One in three Australians with inflammatory bowel disease (IBD) left their medical consultations with misunderstandings about ...
Achieving cost sustainability in inflammatory bowel disease (IBD) care requires expanding access to cost-effective treatments, increasing biosimilar adoption, and implementing policies that reduce ...